J.ophthalmol.(Ukraine).2017;3:30-36.

https://doi.org/10.31288/oftalmolzh201733036

Characteristics of dry eye syndrome in patients with subclinical and manifest hypothyroidism

G.I. Drozhzhyna1

M.I. Pavlovskii2

1 Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine, Odessa, Ukraine

2 Lvov regional clinical hospital, Lvov, Ukraine

E-mail: cornea@te.net.ua

Background. The most common pathology of the thyroid gland is hypothyroidism. The decreased level of thyroid hormones in the body leads to development of hypothyroidism and is accompanied by metabolic, functional, and structural changes in different body organs and tissues including the eye. Thyroid gland disorders are known to be associated with the risk of development of dry eye syndrome (DES). However, the characteristics of the clinical course of DES in subclinical and manifest hypothyroidism remain almost unstudied.

The purpose of the present paper was to reveal clinical characteristics of dry eye syndrome in patients with subclinical and manifest hypothyroidism.

Material and Methods. A total of 87 patients (174 eyes) with primary hypothyroidism, aged 19 to 78 (М=50.5 SD12.5), were studied. The patients were diagnosed primary hypothyroidism by an endocrinologist and had dry eye syndrome. All the patients were recorded with Lvov Regional Clinical Diagnostic and Treatment Endocrinologic Center. Of them, there were 72 (82.8%) women and 15 (17.2%) men. Severity of DES was assessed according to DEWS classification (2007) that included patients’ self-assessment of severity and frequency of subjective symptoms. Tear film break up time (TFBUT), tear production (Schirmer I) test, biomicroscopy of the anterior eye, and fluoroscein staining were also performed.

Results. The patients with subclinical hypothyroidism were more often revealed to have clinical symptoms and objective signs of DES corresponding to stage I and II of the syndrome while the symptoms and clinical signs corresponding to DES stage III were more common in manifest hypothyroidism. The most differences were noted in such signs as discomfort in the eye, conjunctival staining and the presence of inclusions in the tear film. A summed value of tear production was 9.4 (SD5.9) mm in subclinical hypothyroidism while that was significantly lower, in manifest hypothyroidism, 6.1 (SD5.4) mm, (р=0.0002). Stability of tear film was also lower in manifest than in subclinical hypothyroidism, 5.04 (SD2.0) and 5.84 (SD2.2) s, respectively, (р=0.0110). DES stage III was 5 significantly more often revealed in manifest hypothyroidism as compared to the subclinical type, 20 patients (54.1%) and 5 patients (10.0%), respectively, (?2 = 20, 22, р=0.00004).

Conclusions. Tear production disorders are revealed both in subclinical and manifest hypothyroidism. In manifest hypothyroidism, the disorders are more apparent, which is evidenced by a decrease in tear production functional samples and a higher incidence of the severe stage of DES. In this regard, the hypothyroidism patients require ophthalmologist’s examination and follow up for an adequate tear substitute therapy to be prescribed and  keratopathy development to be prevented.

Key words: dry eye syndrome, hypothyroidism, subclinical and manifest hypothyroidism         

References

  1. [Vitamin D and Iodine Deficiency: Impact on Human Health and Aging]. Mizhnarodnyi endokrynologichnyi zhurnal (Conference proceedings). 2016;3(75):82–88. Ukrainian
  2. Dravitsa LV, Biriukov LV, Samokhval NM. [Correction of dry eye syndrome in patients with thyroid pathology]. Conference “Filatov Memorial Lectures”. Odessa; 2014:10-11. Russian.
  3. Mostovoi Yu.M. [Modern classifications and standards of treatment of common diseases of internal organs]. 11th Edition. Vinnytsia: DP “DKF”; 2009: 456-9. Ukrainian.
  4. Pankiv VI. [Syndrome of hyperthyroidism]. Mizhnar. endokrinologichnyi zhurnal. 2012;5(45):136-48. Ukrainian.  
  5. Sviridenko NYi., Kasyanova N.A. [Subclinical hyperthyroidism]. Lechashchii vrach. 2006;10:58-61. Russian. 
  6. Tronko MD. [Guide for a thyroid specialist]. Kyiv; 2010. 92-5. Ukrainian.
  7. Khizhniak OO. [Hyperthyroidism syndrome: clinic, diagnostics, treatment]. Zdorovya Ukrainy. 2012:61-62. Russian.  
  8. Shagun OV., Khamnuieva LYU, Andreeva LS. [Iodine deficiency disorders and hyperthyroidism syndrome: etiology, pathogenesis, diagnostics, treatment]. A study guide. Irkutsk; 2009:32. Russian. 
  9. Bensenor I, Olmas R, Lotufo P. Hypothyroidism in the elderly: diagnosis and management // Clinical Interventions in Aging. 2012; 7:97-111.
    Crossref   Pubmed
  10. Definition and classification of dry eye. Report of the diagnosis and classification Subcommittee of Dry Eye Workshop (DEWS). The Ocular Surface. 2007;5(2):75-92
    Crossref   Pubmed
  11. Dias AC, M?dulo CM, Jorge AG, Braz AM. Influence of thyroid hormone on thyroid hormone receptor beta-1 expression and lacrimal gland and ocular surface morphology. Invest Ophthalmol Vis Sci. 2012;52(7):3038-42.
    Crossref   Pubmed
  12. Eckstein AR, Finkenrath A, Heiligenhaus A et al. Dry eye syndrome in thyrois– associated opthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR–specific autoantibodies. Acta Ophthalmol. Scandinavica. 2004;82:291–7.
    Crossref   Pubmed
  13.  Gatzioufas Z, Panos GD, Brugnolli E, Hafezi F: Corneal topographical and biomechanical variations associated with hypothyroidism. J.Refract Surg. 2014;30(2):78-9
    Crossref   Pubmed
  14. Hoh H, Shirra F, Kienecker C. Lid parallel conjunctival folds (LIPCOF); a definite diagnostic sign of dry eye. Ophthalmol. 1995;92(6):802-8.
  15. Miller W, Narayanan S, Jackson J, The association of bulbar conjunctival folds with other clinical findings in normal and moderate dry eye subjects. Optometry. 2003;74:576–82
  16. Mohanty S, Amruthlal W, Reddy GC: Diagnostic strategies for subclinical hypothyroidism. Indian J.Clin.Biochem. 2010;.25(3):279-82.
  17. Moss S, Klein R, Klein B. Prevalence of risk factors for dry eye syndrome. Arch. Ophthalmol. 2000;118:1264-8.
    Crossref   Pubmed
  18. Ozturk BT, Kerimoglu H, Dikbas O. Ocular changes in primary hyperthyroidism. BMC Reseach Notes. 2010;3:266-71.
  19.  Petruela M, Muresan A, Duncea I. Oxidative Stress and Antioxidant Status in Hypo– and Hyperthyroidism. Antioxidant Enzymes. In Tech. 2012;8:197–236.
  20. Pisani A, Puzzolo D, Spinella R. Effect of hypothyroidism on postnatal conjunctival development in rats. Ophthalmic Res. 2011;45(2):102–12.
    Crossref   Pubmed
  21. Plummer CE, Specht A, Gelatt KN. Ocular manifestations of endocrine disease. Compend Contin Educ Vet. 2013;31(12):733-43.
  22. Shashikala P. Prevalence of dry eye in hypothyroidism. Int. J. Clin. Cases Investigations. 2013:5(1):46-51.
  23. Villanueva I,  Alva-S?nchez C, Pacheco-Rosado J. The Role of Thyroid Hormones as Inductors of Oxidative Stress and Neurodegeneration. Oxidative Medicine and Cellular Longevity. 2013;13:1-15.
    Crossref
  24.  Yilmaz S, Ozan S, Benzer F, Canatan H. Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochem. Funct. 2003;21:325–330. doi:10.1002/cbf.1031  
    Crossref   Pubmed